Entrada Therapeutics Inc (TRDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
Operating Expenses | 18,460 | 14,364 | 9,910 | 8,393 | 0 |
Operating Income | -18,460 | -14,364 | -9,910 | -8,393 | N/A |
Other Income | 13 | -66 | 9 | 13 | 0 |
Pre-tax Income | -18,447 | -14,430 | -9,901 | -8,380 | 0 |
Net Income Continuous | -18,447 | -14,430 | -9,901 | -8,380 | N/A |
Net Income | $-18,447 | $-14,430 | $-9,901 | $-8,380 | $N/A |
EPS Basic Total Ops | 15.85 | -9.78 | -7.56 | -6.67 | N/A |
EPS Basic Continuous Ops | 15.85 | -9.78 | -7.56 | -6.67 | N/A |
EPS Diluted Total Ops | 15.85 | -9.78 | -7.56 | -6.67 | N/A |
EPS Diluted Continuous Ops | 15.85 | -9.78 | -7.56 | -6.67 | N/A |
EBITDA(a) | $-18,096 | $-14,062 | $-9,658 | $-8,194 | $N/A |